Neurol. praxi. 2025;26(4):324-330 | DOI: 10.36290/neu.2025.057

Therapy of tremor

prof. MUDr. Evžen Růžička, DrSc.
Neurologická klinika 1. LF UK a VFN v Praze

Tremor is the most common type of movement disorder, and its precise syndromological classification is essential for effective therapy. This review summarizes current treatment options for the major clinical tremor syndromes, particularly essential tremor, Parkinsonian tremor, dystonic tremor, and functional tremor, as well as less frequent causes including Wilson's disease and multiple sclerosis. Special attention is given to symptomatic pharmacotherapy, with propranolol and primidone remaining the mainstays of treatment for essential tremor, including considerations of dosage, efficacy, and potential risks. The article also discusses alternative pharmacological options, neurosurgical approaches including deep brain stimulation and newer lesion-based techniques, and non-pharmacological strategies in functional tremor. Diagnostic challenges in mixed tremor syndromes are addressed, and the importance of an individualized treatment approach is emphasized.

Keywords: tremor, essential tremor, Parkinson's disease, dystonic tremor, deep brain stimulation, tremor pharmacotherapy.

Received: June 3, 2025; Revised: June 3, 2025; Accepted: July 15, 2025; Prepublished online: July 15, 2025; Published: September 29, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Růžička E. Therapy of tremor. Neurol. praxi. 2025;26(4):324-330. doi: 10.36290/neu.2025.057.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Abusrair AH, Elsekaily W, Bohlega S. Tremor in Parkinson's Disease: From Pathophysiology to Advanced Therapies. Tremor and Other Hyperkinetic Movements. 2022;12(1):29. Go to original source... Go to PubMed...
    2. Bhatia KP, Bain P, Bajaj N, et al. Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society. Movement Disorders. 2018;33(1):75-87. Go to original source... Go to PubMed...
    3. Deuschl G, Antonini A, Costa J, et al. European Academy of Neurology/Movement Disorder Society-European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies. Movement Disorders. 2022;37(7):1360-74. Go to original source... Go to PubMed...
    4. Deuschl G, Raethjen J, Hellriegel H, Elble R. Treatment of patients with essential tremor. The Lancet Neurology. 2011;10(2):148-61. Go to original source... Go to PubMed...
    5. Deuschl G, Raethjen J, Lindemann M, Krack P. The pathophysiology of tremor. Muscle and Nerve. 2001;24(6):716-35. Go to original source... Go to PubMed...
    6. Dirkx MF, Zach H, Bloem BR, et al. The nature of postural tremor in Parkinson disease. Neurology 2018 Mar 27;90(13):e1095-e1103. Go to original source... Go to PubMed...
    7. Elble RJ. Tremor: clinical features, pathophysiology, and treatment. Neurologic Clinics. 2009;27(3):679-95. Go to original source... Go to PubMed...
    8. Elias WJ, Lipsman N, Ondo WG, et al. A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor. N Engl J Med. 2016;375(8):730-9. Go to original source... Go to PubMed...
    9. Espay AJ, Ries S, Maloney T, et al. Clinical and neural responses to cognitive behavioral therapy for functional tremor. Neurology. 2019 Nov 5;93(19):e1787-e1798. Go to original source... Go to PubMed...
    10. Ferreira JJ, Mestre TA, Lyons KE, et al. MDS evidence-based review of treatments for essential tremor. Movement Disorders. 2019;34(7):950-8. Go to original source... Go to PubMed...
    11. Friedman JH, Koller WC, Lannon MC, et al. Benztropine versus clozapine for the treatment of tremor in Parkinson's disease. Neurology. 1997;48(4):1077-80. Go to original source... Go to PubMed...
    12. Gironell A. The GABA Hypothesis in Essential Tremor: Lights and Shadows. Tremor and Other Hyperkinetic Movements. 2014;4(0):254. Go to original source...
    13. Isaacson SH, Peckham E, Tse W, et al. Prospective Home-use Study on Non-invasive Neuromodulation Therapy for Essential Tremor. Tremor and Other Hyperkinetic Movements. 2020;10(0):29. Go to original source... Go to PubMed...
    14. Lenka A, Jankovic J. Tremor Syndromes: An Updated Review. Front Neurol. 2021;12:684835. Go to original source... Go to PubMed...
    15. Low HL, Alexander SK, Misbahuddin A, Gillett GT. Posterior subthalamic area deep brain stimulation for treatment of tremor and dystonia in Wilson's disease. Brain Stimulation. 2019;12(5):1304-6. Go to original source... Go to PubMed...
    16. Maciel R, Portela DC, Xavier-Souza G, et al. Improvement of "Wing-Beating" Tremor in Wilson's Disease With High Dose of Zolpidem: A Case Report. Movement Disord Clin Pract. 2019;6(7):608-9. Go to original source... Go to PubMed...
    17. Madelein Van Der Stouwe AM, Nieuwhof F, Helmich RC. Tremor pathophysiology: lessons from neuroimaging. Current Opinion in Neurology. 2020;33(4):474-81. Go to original source... Go to PubMed...
    18. Marques A, Pereira B, Simonetta-Moreau M, et al. Trial of Botulinum Toxin for Isolated or Essential Head Tremor. N Engl J Med. 2023;389(19):1753-65. Go to original source... Go to PubMed...
    19. Motavasseli D, Delorme C, Bayle N, et al. Use of Botulinum Toxin in Upper-Limb Tremor: Systematic Review and Perspectives. Toxins. 2024;16(9):392. Go to original source... Go to PubMed...
    20. Nevrlý M, Krahulík D, Otruba P, et al. Treating Holmes tremor with deep brain stimulation. Neurol. praxi. 2020;21(2):159-61. Go to original source...
    21. Okelberry T, Lyons KE, Pahwa R. Updates in essential tremor. Parkinsonism & Related Disorders. 2024;122:106086. Go to original source... Go to PubMed...
    22. Paoli D, Mills R, Brechany U, et al. DBS in tremor with dystonia: VIM, GPi or both? A review of the literature and considerations from a single-center experience. J Neurol. 2023;270(4):2217-29. Go to original source... Go to PubMed...
    23. Parihar R, Alterman R, Papavassiliou E, et al. Comparison of VIM and STN DBS for Parkinsonian Resting and Postural/Action Tremor. Tremor and Other Hyperkinetic Movements. 2015 Jul 6;5:321. Go to original source...
    24. Růžička E, Hollý P. Klinická klasifikace třesu. Neurol. praxi. 2020;21(6):428-32. Go to original source...
    25. Růžička E, Jech R, Zárubová K, et al. VIM thalamic stimulation for tremor in a patient with IgM paraproteinaemic demyelinating neuropathy. Movement Disorders. 2003;18(10):1192-5. Go to original source... Go to PubMed...
    26. Schreglmann SR, Wang D, Peach RL, et al. Non-invasive suppression of essential tremor via phase-locked disruption of its temporal coherence. Nat Commun. 2021;12(1):363. Go to original source... Go to PubMed...
    27. Serranová T. Funkční poruchy hybnosti. Neurol. praxi. 2022;23(5):348-54. Go to original source...
    28. Serranová T, Růžička E, Roth J. Funkční poruchy hybnosti. Ces Slov Neurol Neurochir. 2014(77/110(3)):270-86.
    29. Shiramba A, Lane S, Ray N, et al. Efficacy and Safety of Magnetic Resonance-Guided Focused Ultrasound Thalamotomy in Essential Tremor: A Systematic Review and Metanalysis. Movement Disorders. 2025 Jun;40(6):1020-1033. Go to original source... Go to PubMed...
    30. Skorvanek M. Farmakologická liečba trasu. Neurol. praxi. 2020;21(6):439-42.
    31. Zesiewicz TA, Elble RJ, Louis ED, et al. Evidence-based guideline update: Treatment of essential tremor: Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2011;77(19):1752-5. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.